Showing 891-900 of 6907 results for "".
From Bench to Bedside: Reducing Sepsis Mortality
https://reachmd.com/programs/clinicians-roundtable/from-bench-to-bedside-reducing-sepsis-mortality/4009/Sepsis kills 210,000 patients each year. Dr. Peter DeBlieux, professor of medicine at Louisiana State University Health Science Center and director of emergency medicine services at the Medical Center of Louisiana, discusses the latest clinical practice guidelines. He is interviewed by Dr. Shira JohNon-Invasive Brain Stimulation to Treat or Cure Disease
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/non-invasive-brain-stimulation-to-treat-or-cure-disease/3877/A number of illnesses are caused by central nervous system damage. Can a new method of non-invasive brain stimulation treat or cure disease? Join host Dr. Bruce Bloom as he discusses non-invasive neuromodulation of the central nervous system with senior scientists Dr. Kurt Kaczmarek and Dr. Yuri DanOxytocin and Autism: Improved Social Interaction?
https://reachmd.com/programs/clinicians-roundtable/oxytocin-and-autism-improved-social-interaction/3780/Autism has garnered much attention in recent years. One of the most interesting areas of research is the exploration of oxytocin. Could it improve social interaction? Dr. Larry Young, the William P. Timmie Professor at the Center for Behavioral Neuroscience and the Department of Psychiatry at the ETreating Insomnia in Addicts
https://reachmd.com/programs/clinicians-roundtable/treating-insomnia-in-addicts/3758/From alcohol to nicotine to prescription opioids, most substances of abuse can create sleep disturbances that continue even into abstinence. Untreated sleep disturbance can be a significant relapse trigger. Yet, most FDA-approved hypnotics are controlled substances. How can you break the cycle of inSleep Disturbance and Addiction Diagnosis
https://reachmd.com/programs/clinicians-roundtable/sleep-disturbance-and-addiction-diagnosis/3757/Substance abuse and subsequent withdrawal can lead to sleep disturbances. How do you evaluate the substance abuser with sleep difficulties? Dr. Deirdre Conroy, clinical assistant professor of psychiatry at the University of Michigan, joins host Dr. Leslie Lundt to discuss the complex interaction beUnscrambling the Egg Myth
https://reachmd.com/programs/clinicians-roundtable/unscrambling-the-egg-myth/3669/For much of the past 40 years, doctors have been telling patients vulnerable to heart disease to avoid eating eggs because of a mistaken belief that cholesterol-rich eggs increased one's risk of coronary heart disease. Guest Dr. Stephen B. Kritchevsky, director of the Claude D. Pepper Older AmericanDetecting Early Signs of Melanoma
https://reachmd.com/programs/focus-on-cancer/detecting-early-signs-of-melanoma/3642/In the next year, nearly 120,000 new cases of melanoma will be diagnosed in the United States, more than half of which will be invasive disease. Unfortunately, trends indicate the overall incidence will continue to rise in the coming years. Who are the key at-risk populations, and how do we identifyThe Art of Caring for Professional Singers
https://reachmd.com/programs/clinicians-roundtable/the-art-of-caring-for-professional-singers/3626/"A night at the opera" means more than mere entertainment for some. For guest Dr. Anthony Jahn, otolaryngologist and volunteer medical director for the New York Metropolitan Opera, it's part of a second career. Host Dr. Michael Greenberg speaks with Dr. Jahn about his practiced art of caring for proDesvenlafaxine: The Newest Antidepressant
https://reachmd.com/programs/clinicians-roundtable/desvenlafaxine-the-newest-antidepressant/3553/After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do you need to know about this medicine? Host Dr. Leslie Lundt welcomes Dr. Philip Ninan, vice president for Neuroscience Global Medical Affairs at Wyeth PhaDrugmakers' Foray into the Combination Pill Market
https://reachmd.com/programs/clinicians-roundtable/drugmakers-foray-into-the-combination-pill-market/3523/Why take two pills when you can just take one? Welcome to the latest phenomenon in healthcare: combination pills. Tim Walbert, president and chief executive officer of Horizon Therapeutics, tells host Bruce Japsen about the drug industry's push toward combining two or more treatments into one pill,